Related Experiment Video
Updated: Jan 5, 2026

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
Published on: December 9, 2022
RKIP negatively regulates the glucose induced angiogenesis and endothelial-mesenchymal transition in retinal
Le Feng1, Conghui Zhang1, Guodong Liu1
1Department of Ophthalmology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Yanchang Road, Shanghai, 200072, China.
Abstract:
Diabetic retinopathy (DR), a common microvascular complication of diabetes, is reported to be the leading cause of blindness worldwide. In our previous study, we found that the Raf kinase inhibitor protein (RKIP) is significantly decreased in vitreous humor of proliferative diabetic retinopathy (PDR) patients, which indicated that RKIP might play a role in the development of PDR. To investigate the role of RKIP in PDR, stable overexpression and knockdown of RKIP in Human retinal capillary endothelial cells (HRCECs) were generated by using lentivirus constructs. Then, the glucose-induced cell viability, migration, angiogenesis, and (endothelial to mesenchymal transition) EndMT were determined in the RKIP-wide type (WT), -knocking down (KD) and -overexpression (OE) HRCECs. The results showed that, compared with the RKIP-WT groups, the glucose-induced cell viabilities, migration and angiogenesis were significantly increased in the RKIP-KD groups, while significantly decreased in the RKIP-OE groups. Besides, compared with the control groups, CD31 and vWF were upregulated, while α-SMA was downregulated in the RKIP-KD groups, while CD31 and vWF were downregulated, while α-SMA was upregulated in the RKIP-OE groups induced by glucose. In conclusion, our results showed that RKIP negatively regulates glucose-induced cell viability, migration, angiogenesis, and EndMT in HRCECs, suggesting that the downregulation of RKIP in the vitreous humor of PDR patients might contribute to the development of DR.
Insights
Raf kinase inhibitor protein (RKIP) negatively regulates diabetic retinopathy (DR) progression. Lower RKIP levels in the eye promote cell growth, migration, and blood vessel formation, contributing to DR development.
Area of Science:
- Ophthalmology
- Endocrinology
- Molecular Biology
Background:
- Diabetic retinopathy (DR) is a leading cause of blindness globally.
- Reduced Raf kinase inhibitor protein (RKIP) levels are observed in proliferative diabetic retinopathy (PDR).
- RKIP's role in PDR pathogenesis requires further investigation.
Purpose of the Study:
- To investigate the functional role of RKIP in diabetic retinopathy.
- To determine RKIP's effect on human retinal capillary endothelial cells (HRCECs) under high glucose conditions.
- To elucidate RKIP's influence on cell viability, migration, angiogenesis, and endothelial-to-mesenchymal transition (EndMT).
Main Methods:
- Stable RKIP overexpression (OE) and knockdown (KD) were established in HRCECs using lentivirus constructs.
- Cells were exposed to high glucose conditions to mimic the diabetic environment.
- Assays measured cell viability, migration, angiogenesis markers (CD31, vWF), and EndMT markers (α-SMA).
Main Results:
- RKIP knockdown (KD) significantly increased glucose-induced HRCEC viability, migration, and angiogenesis.
- RKIP overexpression (OE) significantly decreased glucose-induced HRCEC viability, migration, and angiogenesis.
- RKIP KD upregulated CD31 and vWF while downregulating α-SMA; RKIP OE showed opposite effects under high glucose.
Conclusions:
- RKIP acts as a negative regulator of glucose-induced cell viability, migration, angiogenesis, and EndMT in HRCECs.
- The observed downregulation of RKIP in PDR patients may contribute to the development and progression of diabetic retinopathy.
- Targeting RKIP could offer a potential therapeutic strategy for managing diabetic retinopathy.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

